Logistics and Cold Chain Challenges in Rapid Delivery of Human Biospecimens for Preclinical Research

Human biospecimens are essential for preclinical research, but their value goes beyond their biological origin. Sample handling, storage, and transport impacts on their quality and, therefore, on the reliability of downstream results.

When temperature control is interrupted, even briefly, biospecimen quality can be compromised in ways that are not always immediately visible.

Maintaining Biospecimen Integrity: Cold Chain Parameters, Stability, and Avoiding Freeze-Thaw Cycles

Temperature is one of the most influential factors affecting human biospecimen quality. The cold chain refers to the temperature-controlled process that must remain continuous from sample collection to delivery to the end user. Its purpose is to protect perishable biological materials and preserve their integrity. Depending on the specimen and its intended use, cold chain conditions may range from refrigerated storage (2-8 °C) to ultra-low temperatures below -150 °C for cryopreserved samples. Even brief deviations outside these ranges can introduce irreversible changes in molecular stability, cell viability, and functional performance.

Beyond absolute temperature, stability over time is equally important. The window between biospecimen collection, processing, storage, and use must be carefully controlled and documented. Delays at any stage can lead to degradation of nucleic acids, proteins, or metabolites, or to reduced cellular functionality.

Repeated freeze-thaw cycles represent a particularly significant risk. Each cycle increases the likelihood of structural damage and variability, even when human biological samples are otherwise well preserved. To mitigate this, biospecimen workflows should be designed to minimize handling steps, limit unnecessary temperature transitions, and use appropriate aliquoting strategies that reduce the need for repeated thawing.

Maintaining biospecimen integrity, therefore, requires more than cold storage alone. It depends on a coordinated approach that considers temperature, time, handling, and the cumulative impact of all pre-analytical variables.

Cold Chain Infrastructure in Human Biospecimen Logistics: Technologies and Monitoring Systems

Effective cold chain logistics rely on technically robust and operationally validated infrastructure. This includes suitable packaging systems, qualified transport conditions, and continuous monitoring throughout storage and shipment.

Shipping containers and packaging materials must be capable of maintaining defined temperature ranges for the full duration of transport, accounting for potential delays and environmental exposure. Specimens should be surrounded by the refrigerant, rather than placed only above or below it, to ensure uniform temperature exposure throughout the shipment. Once specimens and refrigerants are placed inside the shipping container, all remaining space should be filled with absorbent materials, such as padding, foam, or wadded paper. This prevents movement during transport and reduces the risk of mechanical damage caused by vibration or handling.

Equally important is cold chain temperature monitoring. Temperature tracking devices, such as cold chain data loggers, and shipment records, provide objective data on environmental conditions throughout transit. These records enable suppliers and end-users to assess whether biospecimens remain suitable for their intended application upon arrival, rather than relying on assumptions or visual inspection alone.

Cold chain infrastructure extends beyond physical equipment. It also includes standard operating procedures (SOPs) that underpin the chain of custody and proper records. Without documentation systems, traceability, and predefined procedures for reviewing data and responding to deviations, even well-designed logistics systems offer limited assurance of sample quality.

Operational Risks and Delays: Bottlenecks in Sample Transport and International Compliance

Despite careful planning, biospecimen logistics are exposed to a range of operational risks. Transport delays, regulatory barriers, and coordination failures can all compromise sample quality, particularly for fresh biospecimens. 

International shipments present additional complexity. Differences in regulatory requirements, documentation standards, and customs procedures can introduce unpredictable delays. Without prior planning, these delays may exceed validated transport windows, increasing the risk of temperature excursions or extended storage under suboptimal conditions.

Reducing these risks requires collaborating with partners who take into account both local and international regulations and who work with trusted distributors. At BeCytes, a BioIVT company, we support this process by coordinating sourcing, documentation, and logistics to help ensure human biospecimens reach researchers under conditions that preserve their integrity.

Collaborating with Suppliers: Questions to Ask Before Getting Access to Human Biological Samples

Given the complexity of logistics for human biospecimens, close collaboration between researchers and trusted suppliers is essential. The quality of a biospecimen cannot be evaluated solely at the point of receipt; it depends on how it has been handled throughout its journey.

Before getting access to human biological samples, we understand that doubts may arise among researchers:

• How are temperature requirements defined and maintained for this specimen type?

• What systems are used to monitor and document conditions during storage and transport?

• What contingency plans exist in case of transport delays or unexpected deviations?

• How are ethical, legal, and regulatory requirements managed, particularly for cross-border shipments?

At BeCytes, we have developed a dedicated platform to coordinate the donation of human biospecimens for research following high-quality standards according to local and international regulations. The entire process, from donor sample obtention to researchers’ delivery, follows established ISBER Guidelines to ensure the highest quality. 

We achieve our global coverage directly or through our trusted partners and distributors. We rely on a logistic network that allows us to deliver samples worldwide and fresh samples within 24 hours in the European Union and the US.

Contact us to design your tissue sourcing project.

Sources

Snapes E, Astrin JJ, Bertheussen Krüger N, Grossman GH, Hendrickson E, Miller, Seiler C. Updating International Society for Biological and Environmental Repositories Best Practices, Fifth Edition: A New Process for Relevance in an Evolving Landscape. https://www.isber.org/page/BPR.